{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:04:23Z","timestamp":1782691463833,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synthetic glucocorticoids (sGCs) are a well-investigated and standard drug therapy for disorders associated with CNS inflammation. Less is known about treating psychiatric disorders associated with neural autoantibodies. Our aim is to elucidate the repositioning of sGCs in psychiatric diseases that co-exist with neural autoantibodies. We used PubMed to identify articles for this narrative review. To our knowledge, no randomized, placebo-controlled trials have yet been conducted on applying sGC to treat neural autoantibody-associated psychiatric disorders. We describe initial results of cohort studies and single cases or case series often associated with autoantibodies against membrane-surface antigens demonstrating a largely beneficial response to sGCs either as monotherapy or polytherapy together with other immunosuppressive agents. However, sGCs may be less efficient in patients with psychiatric diseases associated with autoantibodies directed against intracellular antigens. These results reveal potential benefits of the novel usage of sGCs for the indication of neural autoantibody-associated psychiatric disease. Further large-scale randomized, placebo-controlled trials are needed to discover whether sGCs are safe, well tolerated, and beneficial in subgroups of neural autoantibody-associated psychiatric diseases.<\/jats:p>","DOI":"10.1007\/s00702-022-02578-2","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T11:05:50Z","timestamp":1672225550000},"page":"1029-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review"],"prefix":"10.1007","volume":"130","author":[{"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Neyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"L\u00fcdecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Malchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CAP (Cerebrospinal Fluid Analysis in Psychiatry) Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"2578_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M et al (2021a) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry 92:897\u2013907. https:\/\/doi.org\/10.1136\/jnnp-2020-325302","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2578_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M et al (2021b) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92:757\u2013768. https:\/\/doi.org\/10.1136\/jnnp-2020-325300","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2578_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, Lennox BR, Okai D, Manohar SG, Irani SR (2019) The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry 6(3):235\u2013246. https:\/\/doi.org\/10.1016\/S2215-0366(19)30001-X","journal-title":"Lancet Psychiatry"},{"key":"2578_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M et al (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87:759\u2013765. https:\/\/doi.org\/10.1212\/WNL.0000000000003009","journal-title":"Neurology"},{"issue":"14","key":"2578_CR5","doi-asserted-by":"publisher","first-page":"175628642199890","DOI":"10.1177\/1756286421998906","volume":"19","author":"SA Banks","year":"2021","unstructured":"Banks SA, Sechi E, Flanagan EP (2021) Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression. Ther Ad Neurol Disord 19(14):1756286421998906. https:\/\/doi.org\/10.1177\/1756286421998906","journal-title":"Ther Ad Neurol Disord"},{"key":"2578_CR6","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1073\/pnas.1901513116","volume":"116","author":"A Barsegyan","year":"2019","unstructured":"Barsegyan A, Mirone G, Ronzoni G, Guo C, Song Q, Kuppeveld DV et al (2019) Glucocorticoid enhancement of recognition memory via basolateral amygdala-driven facilitation of prelimbic cortex interactions. PNAS 116:7077\u20137082. https:\/\/doi.org\/10.1073\/pnas.1901513116","journal-title":"PNAS"},{"key":"2578_CR07","doi-asserted-by":"publisher","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Bl\u00fcmcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135(Pt 5):1622-1638. https:\/\/doi.org\/10.1093\/brain\/aws082","DOI":"10.1093\/brain\/aws082"},{"key":"2578_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1096\/fj.13-237958","volume":"28","author":"L Besedovsky","year":"2014","unstructured":"Besedovsky L, Born J, Lange T (2014) Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4. FASEB J 28:67\u201375. https:\/\/doi.org\/10.1096\/fj.13-237958","journal-title":"FASEB J"},{"key":"2578_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11910-018-0821-y","volume":"18","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Schmitt SE (2018) Treating immune-related epilepsy. Curr Neurol Neurosci Rep 18:10. https:\/\/doi.org\/10.1007\/s11910-018-0821-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2578_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/026988119901300213","volume":"13","author":"M Bodani","year":"1999","unstructured":"Bodani M, Sheehan B, Philpot M (1999) J The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness. J Psychopharmacol 13:196\u2013197. https:\/\/doi.org\/10.1177\/026988119901300213","journal-title":"J Psychopharmacol"},{"key":"2578_CR10","doi-asserted-by":"publisher","first-page":"548469","DOI":"10.3389\/fimmu.2021.548469","volume":"12","author":"PD Burbelo","year":"2021","unstructured":"Burbelo PD, Iadarola MJ, Keller JM, Warner BM (2021) Autoantibodies targeting intracellular and extracellular proteins in autoimmunity. Front Immunol 12:548469. https:\/\/doi.org\/10.3389\/fimmu.2021.548469","journal-title":"Front Immunol"},{"key":"2578_CR11","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.4049\/jimmunol.0903728","volume":"184","author":"AR Burton","year":"2010","unstructured":"Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ et al (2010) Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. J Neuroimmunol 184:4863\u20134870. https:\/\/doi.org\/10.4049\/jimmunol.0903728","journal-title":"J Neuroimmunol"},{"key":"2578_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17:233\u2013247. https:\/\/doi.org\/10.1038\/nri.2017.1","journal-title":"Nat Rev Immunol"},{"key":"2578_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.psychres.2012.09.035","volume":"208","author":"CU Choe","year":"2013","unstructured":"Choe CU, Karamatskos E, Schattling B, Leypoldt F, Liuzzi G, Gerloff C et al (2013) Clinical and neurobiological case of IgM NMDA receptor\u00a0antibody\u00a0associated encephalitis mimicking bipolar disorder. Psychiatry Res 208:194\u2013196. https:\/\/doi.org\/10.1016\/j.psychres.2012.09.035","journal-title":"Psychiatry Res"},{"key":"2578_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/jlb.66.2.201","volume":"66","author":"EC De Jong","year":"1999","unstructured":"De Jong EC, Vieira PL, Kalinski P, Kapsenberg ML (1999) Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 66:201\u2013204. https:\/\/doi.org\/10.1002\/jlb.66.2.201","journal-title":"J Leukoc Biol"},{"key":"2578_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acn3.120","volume":"1","author":"S Doss","year":"2014","unstructured":"Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B et al (2014) High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types. Ann Clin Transl Neurol 1:822\u2013832. https:\/\/doi.org\/10.1002\/acn3.120","journal-title":"Ann Clin Transl Neurol"},{"key":"2578_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720002895","author":"D Endres","year":"2020","unstructured":"Endres D, Maier V, Leypoldt F, Wandinger KP, Lennox B, Pollak TA et al (2020) Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases. Psychol Med. https:\/\/doi.org\/10.1017\/S0033291720002895. (Online ahead of print)","journal-title":"Psychol Med"},{"key":"2578_CR17","doi-asserted-by":"publisher","first-page":"105320","DOI":"10.1016\/j.psyneuen.2021.105320","volume":"131","author":"D Endres","year":"2021","unstructured":"Endres D, Runge K, Meixensberger S, Feige B, Denzel D, Pankratz B et al (2021) An observational study on the association of anti-thyroid autoantibodies with clinical, EEG, MRI, FDG-PET, cerebrospinal fluid and anti-neuronal antibody findings in 530 patients with schizophreniform and affective disorders. Psychoneuroendocrinology 131:105320. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105320","journal-title":"Psychoneuroendocrinology"},{"key":"2578_CR18","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1038\/s41380-022-01688-3","volume":"27","author":"D Endres","year":"2022","unstructured":"Endres D, Pankratz B, Robinson T, Pitsch K, G\u00f6bel T, Runge K et al (2022a) Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid. Mol Psychiatry 27:3926\u20133928. https:\/\/doi.org\/10.1038\/s41380-022-01688-3","journal-title":"Mol Psychiatry"},{"key":"2578_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000522136","volume":"91","author":"D Endres","year":"2022","unstructured":"Endres D, Mertens L, Berger B, Reisert M, Runge K, Nickel K et al (2022b) Autoimmune obsessive-compulsive disorder with novel anti-basal ganglia antibodies. Psychother Psychosom 91:214\u2013216. https:\/\/doi.org\/10.1159\/000522136","journal-title":"Psychother Psychosom"},{"key":"2578_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41380-021-01396-4","volume":"27","author":"D Endres","year":"2022","unstructured":"Endres D, L\u00fcngen E, Hasan A, Kluge M, Fr\u00f6hlich S, Lewerenz J et al (2022c) Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany. Mol Psychiatry 27:1479\u20131489. https:\/\/doi.org\/10.1038\/s41380-021-01396-4","journal-title":"Mol Psychiatry"},{"key":"2578_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","volume":"12","author":"D Endres","year":"2022","unstructured":"Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, ECNP Network Immuno-NeuroPsychiatry, Domschke K, Tebartz van Elst L, Schiele MA et al (2022d) Immunological causes of\u00a0obsessive-compulsive\u00a0disorder: is it time for the concept of an \u201cautoimmune OCD\u201d subtype? Transl Psychiatry 12:5. https:\/\/doi.org\/10.1038\/s41398-021-01700-4","journal-title":"Transl Psychiatry"},{"key":"2578_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","volume":"169","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I (2012) Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169:491\u2013497. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11071009","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"2578_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2013.04.001","volume":"380","author":"HJ Fischer","year":"2013","unstructured":"Fischer HJ, Schweingruber N, L\u00fchder F, Reichardt HM (2013) The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Mol Cell Endocrinol 380(1\u20132):99\u2013107. https:\/\/doi.org\/10.1016\/j.mce.2013.04.001. (Epub 2013 Apr 8)","journal-title":"Mol Cell Endocrinol"},{"key":"2578_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4065\/mcp.2010.0326","volume":"85","author":"EP Flanagan","year":"2010","unstructured":"Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM (2010) Autoimmune Dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc 85:881\u2013897. https:\/\/doi.org\/10.4065\/mcp.2010.0326","journal-title":"Mayo Clin Proc"},{"key":"2578_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5498\/wjp.v7.i3.177","volume":"7","author":"G Gazdag","year":"2017","unstructured":"Gazdag G, Takacs R, Ungvari GS (2017) Catatonia as a putative nosological entity: a historical sketch. World J Psychiatry 7:177\u2013183","journal-title":"World J Psychiatry"},{"issue":"8","key":"2578_CR26","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00415-020-09825-0","volume":"268","author":"LL Gibson","year":"2021","unstructured":"Gibson LL, McKeever A, Cullen AE, Nicholson TR, Aarsland D, Zandi et al (2021) Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis. J Neurol 268(8):2769\u20132779. https:\/\/doi.org\/10.1007\/s00415-020-09825-0","journal-title":"J Neurol"},{"key":"2578_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"2578_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","volume":"65","author":"N Hansen","year":"2016","unstructured":"Hansen N, Widman G, Witt JA, Wagner J, Becker AJ, Elger CE, Helmstaedter C (2016) Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis. Epilepsy Behav 65:18\u201324. https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.016","journal-title":"Epilepsy Behav"},{"key":"2578_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fpsyt.2020.00576","volume":"11","author":"N Hansen","year":"2020","unstructured":"Hansen N, Hirschel S, St\u00f6cker W, Manig A, Falk HS, Ernst M, Vukovich R, Zerr I, Wiltfang J, Bartels C (2020a) figural memory impairment in conjunction with neuropsychiatric symptoms in IgLON5 antibody-associated autoimmune encephalitis. Front Psychiatry 11:576. https:\/\/doi.org\/10.3389\/fpsyt.2020.00576","journal-title":"Front Psychiatry"},{"key":"2578_CR30","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.bbih.2020.100154","volume":"9","author":"N Hansen","year":"2020","unstructured":"Hansen N, Lipp M, Vogelgsang J, Vukovich R, Zindler T, Luedecke D, CAP (Cerebrospinal Fluid Analysis in Psychiatry) Consortium et al (2020b) Autoantibody-associated psychiatric symptoms and syndromes in adults: a narrative review and proposed diagnostic approach. Brain Behav Immunity Health 9:100154","journal-title":"Brain Behav Immunity Health"},{"key":"2578_CR31","doi-asserted-by":"publisher","first-page":"626121","DOI":"10.3389\/fpsyt.2021.626121","volume":"12","author":"N Hansen","year":"2021","unstructured":"Hansen N, Bartels C, St\u00f6cker W, Wiltfang J, Tim\u00e4us C (2021a) Case report: anti-flotillin 1\/2 autoantibody-associated atypical dementia. Front Psychiatry. 12:626121. https:\/\/doi.org\/10.3389\/fpsyt.2021.626121","journal-title":"Front Psychiatry."},{"key":"2578_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/brainsci11060673","volume":"11","author":"N Hansen","year":"2021","unstructured":"Hansen N, Lange C, Maass F, Hassoun L, Bouter C, St\u00f6cker W, Schott BH, Wiltfang J, Fitzner D (2021b) Mild amnestic cognitive impairment and depressive symptoms in autoimmune encephalitis associated with serum anti-neurexin-3\u03b1 autoantibodies. Brain Sci 11:673. https:\/\/doi.org\/10.3390\/brainsci11060673","journal-title":"Brain Sci"},{"key":"2578_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00702-021-02316-0","volume":"128","author":"N Hansen","year":"2021","unstructured":"Hansen N, Malchow B, Zerr I, St\u00f6cker W, Wiltfang J, Tim\u00e4us C (2021c) Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort. J Neural Transm\u00a0(vienna) 128:357\u2013369. https:\/\/doi.org\/10.1007\/s00702-021-02316-0","journal-title":"J Neural Transm\u00a0(vienna)"},{"key":"2578_CR34","doi-asserted-by":"publisher","first-page":"856876","DOI":"10.3389\/fnagi.2022.856876","volume":"14","author":"N Hansen","year":"2022","unstructured":"Hansen N, Hirschel S, Rentzsch K, Wiltfang J, Malchow B, Fitzner D (2022) Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: retrospective case series. Front Aging Neurosci 14:856876. https:\/\/doi.org\/10.3389\/fnagi.2022.856876","journal-title":"Front Aging Neurosci"},{"key":"2578_CR35","doi-asserted-by":"publisher","first-page":"611597","DOI":"10.3389\/fneur.2021.611597","volume":"12","author":"Z Hayden","year":"2021","unstructured":"Hayden Z, B\u00f3n\u00e9 B, Orsi G, Szots M, Nagy F, Cs\u00e9p\u00e1ny T et al (2021) Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort. Front Neurol 12:611597. https:\/\/doi.org\/10.3389\/fneur.2021.611597","journal-title":"Front Neurol"},{"issue":"2","key":"2578_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/8755122520978534","volume":"37","author":"G Huynh","year":"2021","unstructured":"Huynh G, Reinert JP (2021) Steroid-induced psychosis: a review of patient cases. J Pharm Technol 37(2):120\u2013126. https:\/\/doi.org\/10.1177\/8755122520978534","journal-title":"J Pharm Technol"},{"key":"2578_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbi.2020.08.028","volume":"90","author":"R Jeppesen","year":"2020","unstructured":"Jeppesen R, Christensen RHB, Pedersen EMJ, Nordentoft M, Hjorth\u00f8j C, K\u00f6hler-Forsberg O, Benros ME (2020) Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders\u2014a comprehensive systematic review and meta-analysis. Brain Behav Immun 90:364\u2013380. https:\/\/doi.org\/10.1016\/j.bbi.2020.08.028","journal-title":"Brain Behav Immun"},{"key":"2578_CR38","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711000183","volume-title":"Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus","author":"J Kukolja","year":"2011","unstructured":"Kukolja J, Klingm\u00fcller D, Maier W, Fink GR, Hurlemann R (2011) Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus. Cambridge University Press, Cambridge (published online)"},{"key":"2578_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fendo.2018.00235","volume":"9","author":"AC Liberman","year":"2018","unstructured":"Liberman AC, Budzi\u00f1ski ML, Sokn C, Gobbini RP, Steininger A, Arzt E (2018) Regulatory and mechanistic actions of glucocorticoids on T and inflammatory cells. Front Endocrinol\u00a0(lausanne) 9:235. https:\/\/doi.org\/10.3389\/fendo.2018.00235","journal-title":"Front Endocrinol\u00a0(lausanne)"},{"issue":"7","key":"2578_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41590-022-01244-9","volume":"23","author":"Z Liu","year":"2022","unstructured":"Liu Z, Hu X, Liang Y, Yu J, Li H, Shokhirev MN, Zheng Y (2022) Glucocorticoid\u00a0signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche. Nat Immunol 23(7):1086\u20131097. https:\/\/doi.org\/10.1038\/s41590-022-01244-9. (Epub 2022 Jun 23)","journal-title":"Nat Immunol"},{"key":"2578_CR041","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/acn3.444","volume":"4","author":"M Malviya","year":"2017","unstructured":"Malviya M, Barman S, Golombeck KS, Planagum\u00e0 J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, B\u00f6nte K, Johnen A, Wandinger KP, Mart\u00edn-Garc\u00eda E, Becker AJ, Elger CE, Kl\u00f6cker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N (2017) NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Ann Clin Transl Neurol 4:768\u2013783. https:\/\/doi.org\/10.1002\/acn3.444","journal-title":"Ann Clin Transl Neurol"},{"key":"2578_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04365-4","author":"LG Nasib","year":"2020","unstructured":"Nasib LG, Sommer IE, Winter-van Rossum I, de Vries J et al (2020) Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design. Trials. https:\/\/doi.org\/10.1186\/s13063-020-04365-4","journal-title":"Trials"},{"key":"2578_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak TA, Lennox BR, M\u00fcller S, Benros ME, Pr\u00fcss H, Tebartzvanelst L et al (2020) Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry 7:93\u2013108. https:\/\/doi.org\/10.1016\/S2215-0366(19)30290-1","journal-title":"Lancet Psychiatry"},{"key":"2578_CR43","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","volume":"78","author":"H Pr\u00fcss","year":"2012","unstructured":"Pr\u00fcss H, H\u00f6ltje M, Maier N, Gomez A, Buchert R, Harms L et al (2012) IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 78:1743\u20131753. https:\/\/doi.org\/10.1212\/WNL.0b013e318258300d","journal-title":"Neurology"},{"key":"2578_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA (2016) Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin N Am. 42:15\u201331. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.002","journal-title":"Rheum Dis Clin N Am."},{"key":"2578_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.psym.2019.03.002","volume":"61","author":"M Restrepo-Mart\u00ednez","year":"2020","unstructured":"Restrepo-Mart\u00ednez M, Chac\u00f3n-Gonz\u00e1lez J, Bayliss L, Ram\u00edrez-Berm\u00fadez J, Fricchione GL, Espinola-Nadurille M (2020) Delirious mania as a neuropsychiatric presentation in patients with anti-N-methyl-d-aspartate receptor encephalitis. Psychosomatics 61:64\u201369. https:\/\/doi.org\/10.1016\/j.psym.2019.03.002","journal-title":"Psychosomatics"},{"key":"2578_CR46","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med 353:1711\u20131723. https:\/\/doi.org\/10.1056\/NEJMra050541","journal-title":"N Engl J Med"},{"key":"2578_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jad.2021.03.034","volume":"287","author":"CN Rivera-Bonet","year":"2021","unstructured":"Rivera-Bonet CN, Birn RM, Ladd CO, Meyerand ME, Abercrombie HC (2021) Cortisol effects on brain functional connectivity during emotion processing in women with depression. J Affect Dis 287:247\u2013254. https:\/\/doi.org\/10.1016\/j.jad.2021.03.034","journal-title":"J Affect Dis"},{"key":"2578_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","volume":"93","author":"A Rodriguez","year":"2022","unstructured":"Rodriguez A, Klein CJ, Alden E, Basso MR, Pudumjee S, Pittock SJ et al (2022) LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry 93:309\u2013315. https:\/\/doi.org\/10.1136\/jnnp-2021-327302","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2578_CR49","doi-asserted-by":"publisher","first-page":"577082","DOI":"10.1016\/j.jneuroim.2019.577082","volume":"338","author":"KM Ryan","year":"2020","unstructured":"Ryan KM, Boyle NT, Harkin A, Connor TJ (2020) Dexamethasone attenuates inflammatory-mediated suppression of \u03b22-adrenoceptor expression in rat primary mixed glia. J Neuroimmunol 338:577082. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577082","journal-title":"J Neuroimmunol"},{"key":"2578_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/practneurol-2019-002388","volume":"20","author":"K Samra","year":"2020","unstructured":"Samra K, Rogers J, Mahdi-Rogers M, Stanton B (2020) Catatonia with GABAA receptor antibodies. Pract Neurol 20:139\u2013143. https:\/\/doi.org\/10.1136\/practneurol-2019-002388","journal-title":"Pract Neurol"},{"key":"2578_CR51","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.03.001","volume":"87","author":"F Spiga","year":"2020","unstructured":"Spiga F, Zhao Z, Lightman SL (2020) Prolonged treatment with the synthetic glucocorticoid methylprednisolone affects adrenal steroidogenic function and response to inflammatory stress in the rat. Brain Behav Immun 87:703\u2013714. https:\/\/doi.org\/10.1016\/j.bbi.2020.03.001","journal-title":"Brain Behav Immun"},{"issue":"10","key":"2578_CR52","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.1007\/s12035-016-0277-5","volume":"54","author":"M Srinivasan","year":"2017","unstructured":"Srinivasan M, Lahiri DK (2017) Glucocorticoid-induced leucine zipper in central nervous system health and disease. Mol Neurobiol 54(10):8063\u20138070. https:\/\/doi.org\/10.1007\/s12035-016-0277-5","journal-title":"Mol Neurobiol"},{"key":"2578_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","volume":"21","author":"MD Taves","year":"2021","unstructured":"Taves MD, Ashwell JD (2021) Glucocorticoids in T cell development, differentiation and function. Nat Rev Immunol 21:233\u2013243. https:\/\/doi.org\/10.1038\/s41577-020-00464-0","journal-title":"Nat Rev Immunol"},{"key":"2578_CR54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00406-019-01049-2","volume":"269","author":"F Thibaut","year":"2019","unstructured":"Thibaut F (2019) Corticosteroid-induced psychiatric disorders: genetic studies are needed. Eur Arch Psychiatry Clin Neurosci 269:623\u2013625. https:\/\/doi.org\/10.1007\/s00406-019-01049-2","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"2578_CR55","doi-asserted-by":"publisher","first-page":"fcaa233","DOI":"10.1093\/braincomms\/fcaa233","volume":"3","author":"C Valencia-Sanchez","year":"2021","unstructured":"Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A (2021) Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun 3(2):fcaa233. https:\/\/doi.org\/10.1093\/braincomms\/fcaa233","journal-title":"Brain Commun"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-022-02578-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:21:00Z","timestamp":1690474860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-022-02578-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s00702-022-02578-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AH received paid speakership from Lundbeck, Otsuka, Rovi, Recordati, and Janssen and was member of advisory boards of these companies. He is editor of the German S3-guideline schizophrenia and the WFSBP schizophrenia guidelines. NH, AN, DL, JW, and BM reported no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}